The Global Metastatic Prostate Cancer Market is estimated to be valued at USD 12.80 Bn in 2025 and is expected to reach USD 22.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2032. https://timessquarereporter.com/news/metastatic-prostate-cancer-market-is-estimated-to-witness-high-growth-owing-to-next-gen-precision-oncology-therapies